Key result
TFE3 immunohistochemistry was found to be a very useful marker for the diagnosis of alveolar soft part sarcoma of the larynx.
Case Report (n=1)
TFE3 immunohistochemistry is a useful diagnostic marker for alveolar soft part sarcoma, even in extremely rare locations such as the larynx.
Supports TFE3 IHC for laryngeal alveolar soft part sarcoma diagnosis; leaves open validation in larger series.
BACKGROUND: Alveolar soft part sarcoma (ASPS) is a rare mesenchymal neoplasm of uncertain origin. In this article, we report a case of ASPS occurring in the larynx, an extremely rare location for this rather unusual tumor. METHODS AND RESULTS: The patient was a 34-year-old Japanese woman who requested an examination for hoarseness. The tumor showed a proliferation of large polygonal cells with periodic-acid-Schiff-positive diastase-resistant intracytoplasmic granules, arranged in an alveolar growth pattern. The cytoplasm of the tumor cells was eosinophilic. Tumor cells were positive for vimentin and titin. Nuclear immunoreactivity for TFE3 was observed, and the Ki-67 labeling index was 14.7%. Ultrastructurally, electron-dense rod-shaped crystals were infrequently observed in the cytoplasm. This case was finally diagnosed as ASPS of the larynx. CONCLUSION: We discuss the histogenesis and differential diagnosis of ASPS with immunohistochemical and ultrastructural findings. TFE3 immunohistochemistry was found to be a very useful marker for the diagnosis of ASPS.
No takes yet. Share an insight, caveat, or question.
Kusafuka et al. (2008) conducted a case report in Alveolar soft part sarcoma (ASPS) of the larynx (n=1). TFE3 immunohistochemistry was evaluated. TFE3 immunohistochemistry was found to be a very useful marker for the diagnosis of alveolar soft part sarcoma of the larynx.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: